Recent advances in the development of peptide-based inhibitors targeting epigenetic readers of histone lysine acetylation and methylation marks
- DOI
- 10.1016/j.cbpa.2023.102334
- Published
- 2023-08
- Container
- Current Opinion in Chemical Biology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.cbpa.2023.102334,
title = {Recent advances in the development of peptide-based inhibitors targeting epigenetic readers of histone lysine acetylation and methylation marks},
author = {Sha Liu and Xiang Li and Xin Li and Xiang David Li},
year = {2023},
journal = {Current Opinion in Chemical Biology},
doi = {10.1016/j.cbpa.2023.102334},
url = {https://doi.org/10.1016/j.cbpa.2023.102334}
}RIS
TY - JOUR TI - Recent advances in the development of peptide-based inhibitors targeting epigenetic readers of histone lysine acetylation and methylation marks AU - Sha Liu AU - Xiang Li AU - Xin Li AU - Xiang David Li PY - 2023 JO - Current Opinion in Chemical Biology DO - 10.1016/j.cbpa.2023.102334 UR - https://doi.org/10.1016/j.cbpa.2023.102334 ER -
APA
Liu, S., Li, X., Li, X., & Li, X. D. (2023). Recent advances in the development of peptide-based inhibitors targeting epigenetic readers of histone lysine acetylation and methylation marks. Current Opinion in Chemical Biology. https://doi.org/10.1016/j.cbpa.2023.102334
Source records
- crossref · retrieved 2026-09-25T14:18:56.938Z